ORIGINAL RESEARCH
Published on 27 May 2025
Efficacy and safety of Tislelizumab combined with Axitinib as first-line treatment for intermediate- and high-risk metastatic clear-cell renal cell carcinoma
doi 10.3389/fphar.2025.1618898
- 274 views
1,091
Total downloads
6,085
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
ORIGINAL RESEARCH
Published on 27 May 2025
ORIGINAL RESEARCH
Published on 22 Apr 2025
ORIGINAL RESEARCH
Published on 15 Apr 2025
ORIGINAL RESEARCH
Published on 01 Apr 2025
ORIGINAL RESEARCH
Published on 28 Mar 2025
ORIGINAL RESEARCH
Published on 27 Mar 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: